Vnitr Lek 2011, 57(4):402-404

Metabolic surgery - a new approach to the management of selected diseases

M. Fried1,2,*, K. Doležalová1
1 Centrum pro léčbu obezity a metabolických poruch OB kliniky Praha, přednosta prof. MUDr. Martin Fried, CSc.
2 1. lékařská fakulta UK Praha, děkan prof. MUDr. Tomáš Zima, DrSc., MBA

Treatment options for type 2 diabetes have changed dramatically in the past few years. Experimental works followed by evidence based studies proved long-term efficacy of metabolic surgery in type 2 diabetes treatment. Moreover diabetes resolution is not directly correlated with weight loss and occurs independently to it. Large literature metaanalyses showed that type 2 diabetes can be subtantially improved with metabolic surgery in about 85 % of all diabetic patients, out of which can be resolved in more than 75%. Metabolic surgery affects hormonal secretion on multiple levels namely in the small intestine. Restrictive as well as combined and malabsorptive surgical procedures have positive effect on type 2 diabetes improvement as well as on metabolic syndrome, sleep apnea syndrome and on other comorbidities.

Keywords: metabolic surgery; type 2 diabetes mellitus; surgical treatment of diabetes

Received: March 13, 2011; Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fried M, Doležalová K. Metabolic surgery - a new approach to the management of selected diseases. Vnitr Lek. 2011;57(4):402-404.
Download citation

References

  1. Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256. Go to original source... Go to PubMed...
  2. Fried M et al. Bariatrická a metabolická chirurgie, nové postupy v léčbě obezity a metabolických poruch. Praha: Mladá Fronta 2011.
  3. Scopinaro N, Marinari G, Camerini G et al. 2004 ABS Consensus Conference. Biliopancreatic diversion for obesity: state of the art. Surg Obes Relat Dis 2005; 1: 317-328. Go to original source... Go to PubMed...
  4. Adami GF, Cordera R, Camerini G et al. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 2004; 28: 671-673. Go to original source... Go to PubMed...
  5. Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323. Go to original source... Go to PubMed...
  6. Ponce J, Haynes B, Paynter S et al. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 2004; 14: 1335-1342. Go to original source... Go to PubMed...
  7. Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484. Go to original source... Go to PubMed...
  8. Adami GF, Cordera R, Camerini G et al. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 2003; 113: 217-221. Go to original source... Go to PubMed...
  9. Scopinaro N, Adami GF, Papadia FS et al. Effects of Biliopanceratic Diversion on Type 2 Diabetes in Patients With BMI 25 to 35. Ann Surg 2011; 253: 699-703. Go to original source... Go to PubMed...
  10. American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care 2010; 33 (Suppl 1): S11-S61. Go to original source... Go to PubMed...
  11. Buchwald H, Estok R, Fahrbach K et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142: 621-632. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.